(Reuters) -An experimental drug from Eli Lilly works best if Alzheimer’s patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease, researchers said on Monday, signaling the latest promising development for treating the most common form of dementia. Read full story